Literature DB >> 1827289

EORTC joint ventures in quality control: treatment-related variables and data acquisition in chemotherapy trials.

K Vantongelen1, W Steward, G Blackledge, J Verweij, A Van Oosterom.   

Abstract

In multicentre studies, non-compliance with the protocol may limit the chances of reaching a correct conclusion. A procedure to examine the administration of chemotherapy in multicentre EORTC protocols has been developed. General aspects are covered in a mailed questionnaire on the prescription of drugs with rounding up or down of dosages, local facilities for preparation and the procedure for preparation and administration. More detail is collected during a quality control site visit. Ten centres have been visited and there was significant variation between centres in the organisation of chemotherapy administration. However, more striking differences were noted between the type and quality of hospital files. The lack of systematic recording of sequence, timing and doses of chemotherapy and, in particular, treatment related toxicity, is a major difficulty limiting the effectiveness of quality control. These shortcomings emphasise the need for standardisation of some aspects of case records and a suggested check-list has been drafted.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1827289     DOI: 10.1016/0277-5379(91)90488-y

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  3 in total

1.  Febrile neutropenic events in cancer patients: treatment for fever and neutropenia in young adult patients during intensive chemotherapy for solid tumours.

Authors:  M Nobbenhuis; F J Cleton
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

Review 2.  Oncology data management in the UK--BODMA's view. British Oncology Data Managers Association.

Authors:  D Riley; L Ward; T Young
Journal:  Br J Cancer       Date:  1994-09       Impact factor: 7.640

3.  Generating evidence on a risk-based monitoring approach in the academic setting - lessons learned.

Authors:  Belinda von Niederhäusern; Annette Orleth; Sabine Schädelin; Nawal Rawi; Martin Velkopolszky; Claudia Becherer; Pascal Benkert; Priya Satalkar; Matthias Briel; Christiane Pauli-Magnus
Journal:  BMC Med Res Methodol       Date:  2017-02-14       Impact factor: 4.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.